Featured Research

from universities, journals, and other organizations

Iowa Study Suggests Promising Treatment For Diabetic Pregnancies

Date:
May 5, 1999
Source:
University Of Iowa
Summary:
Pregnant women with diabetes must deal with the costly and difficult tasks of checking their glucose levels and taking insulin several times daily in an effort to ensure their babies are born without birth defects. However, there may be a better way of handling the blood glucose condition during pregnancies, according to results from a University of Iowa study.

IOWA CITY, Iowa -- Pregnant women with diabetes must deal with the costly and difficult tasks of checking their glucose levels and taking insulin several times daily in an effort to ensure their babies are born without birth defects. However, there may be a better way of handling the blood glucose condition during pregnancies, according to results from a University of Iowa study.

Related Articles


Stephen Hunter, M.D., Ph.D., UI assistant professor of obstetrics and gynecology, and his colleagues are investigating whether a transplant of specially encapsulated pancreatic islet cells can control a woman's diabetes during pregnancy. Pancreatic islet cells produce insulin, a hormone that becomes deficient in people with diabetes. The UI researchers have already tested the islet cell treatment on mice with great success.

"Successful use of this treatment in pregnancies complicated by diabetes would be a significant advancement for these patients and a major breakthrough in the battle against diabetes-induced birth defects," Hunter said.

An estimated 1.5 million women of child-bearing age in the United States have diabetes. A diabetic pregnancy is one of the leading causes of birth defects, Hunter said. A woman with diabetes is two to five times more likely to give birth to a baby with a birth defect than a woman without the condition.

Many researchers have investigated how to transplant the pancreatic islet cells into people with diabetes as a way to treat the condition permanently; however, there are problems with using the islet cells for life-long diabetes control because the body rejects the cells unless powerful anti-rejections drugs are used.

To prevent rejection without the need for anti-rejection drugs, investigators are encapsulating the pancreatic islet cells within a gelatin. The material allows small substances such as glucose and insulin to pass freely but prevents the large molecules and cells of the immune system from interacting with the islet cells and thereby prevents rejection. Unfortunately, the encapsulated islet cells do not survive for long periods of time because the isolating material decreases oxygen supply to the cells. However, in the case of a relatively short-term use, such as pregnancy, Hunter thought the approach might work.

Hunter tested his hypothesis using mice. His results showed that the mice treated with the encapsulated islet cells had significantly lower blood glucose levels throughout their pregnancies and were significantly less likely to give birth to pups with malformations (3.0 - 5.4 percent in the treated diabetic mice versus 40 - 50 percent in their untreated counterparts).

Hunter's study appears in a recent issue of the American Society for Artificial Internal Organs Journal.

Although the results are promising, there is still work to be done before researchers can test the treatment in humans, Hunter said. Many of the treated mice experienced hypoglycemia. Hunter is not exactly sure why this happened, but he speculated that it may involve an inability of isolated, encapsulated islets to communicate with one another and coordinate the total insulin secreted among them. Hunter and his colleagues are looking at how to produce genetically engineered islet cells to avoid this problem as well as how to improve the cells' use of oxygen and their ability to avoid rejection without the use of a protective barrier.

Hunter also wants to find a better way to implant the cells. In the mice, Hunter placed the cells directly into the abdomen's peritoneal cavity. Hunter would like to devise a way to implant the cells under the skin where doctors could remove the cells if complications arose.


Story Source:

The above story is based on materials provided by University Of Iowa. Note: Materials may be edited for content and length.


Cite This Page:

University Of Iowa. "Iowa Study Suggests Promising Treatment For Diabetic Pregnancies." ScienceDaily. ScienceDaily, 5 May 1999. <www.sciencedaily.com/releases/1999/05/990505065852.htm>.
University Of Iowa. (1999, May 5). Iowa Study Suggests Promising Treatment For Diabetic Pregnancies. ScienceDaily. Retrieved March 30, 2015 from www.sciencedaily.com/releases/1999/05/990505065852.htm
University Of Iowa. "Iowa Study Suggests Promising Treatment For Diabetic Pregnancies." ScienceDaily. www.sciencedaily.com/releases/1999/05/990505065852.htm (accessed March 30, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, March 30, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Soda, Salt and Sugar: The Next Generation of Taxes

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Dinι Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline. Video provided by Washington Post
Powered by NewsLook.com
UnitedHealth Buys Catamaran

UnitedHealth Buys Catamaran

Reuters - Business Video Online (Mar. 30, 2015) — The $12.8 billion merger will combine the U.S.&apos; third and fourth largest pharmacy benefit managers. Analysts say smaller PBMs could also merge. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com
These Popular Antibiotics Can Cause Permanent Nerve Damage

These Popular Antibiotics Can Cause Permanent Nerve Damage

Newsy (Mar. 27, 2015) — A popular class of antibiotic can leave patients in severe pain and even result in permanent nerve damage. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins